Post-myocardial infarction pericarditis occurs in approximately 5% to 6% of patients who receive thrombolytic agents. It should be suspected in any patient with pleuropericardial pain. A pericardial friction rub may or may not be present. Differentiation of pericarditis from recurrent angina may be difficult, but a careful history and evaluation of serial electrocardiograms can help distinguish the two entities. Dressler’s syndrome, pericarditis that occurs at least 1 week following myocardial infarction, is now exceedingly rare. Most cases of pericarditis have a benign course; however, because pericarditis is associ-ated with larger infarcts, overall long-term mortality rate is increased. Rare complications include hemopericardium, cardiac tamponade, and constrictive pericarditis. Therapy is directed toward relief of pain, which usually responds well to nonsteroidal anti-inflammatory agents (eg, aspirin or ibuprofen).
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
References and Recommended Reading
Correale E, Maggioni AP, Romano S, et al.: Comparison of frequency, diagnostic and prognostic significance of pericardial involvement in acute myocardial infarction treated with and without thrombolytics. Am J Cardiol 1993, 71:1377–1381. This important paper determines the incidence and prognos-tic significance of pericarditis in the GISSI-1 and GISSI-2 database. This paper is often quoted for its finding that thrombolytic therapy halves the frequency of pericarditis.
Dressler W: The post-myocardial infarction syndrome. A report of forty-four cases. Arch Intern Med 1959, 103:28–41.
Lichstein E, Arsura E, Hollander G, et al.: Current incidence of postmyocardial infarction (Dressler’s) syndrome. Am J Cardiol 1982, 50:1269–1271.
Tofler GH, Muller JE, Stone PH, et al.: Pericarditis in acute myocardial infarction: characterization and clinical significance. Am Heart J 1989, 117:86–90. This paper describes the findings of the Multicenter Investi-gation of the Limitation of Infarct Size (MILIS) study, which was designed to examine the effects of propranolol and hyaluronidase on infarct size. Patients who developed pericarditis were prospectively followed, and the outcomes are analyzed in this paper.
Correale E, Maggioni AP, Romano S, et al.: Pericardial involvement in acute myocardial infarction in the post-thrombolytic era: clinical meaning and value. Clin Cardiol 1997, 20:327–331. This paper reviews the pathophysiology and difficulties in diagnosis of post-myocardial infarction pericarditis and discusses long-term outcome.
Oliva PB, Hammill SC, Edwards WD: Electrocardio-graphic diagnosis of postinfarction regional pericarditis. Ancillary observations regarding the effect of reperfusion on the rapidity and amplitude of T wave inversion after acute myocardial infarction. Circulation 1993, 88:896–904.
Oliva PB, Hammill SC: The clinical distinction between postinfarction pericarditis and other causes of postinfarction chest pain: ancillary observations regarding the effect of lytic therapy upon the frequency of postinfarction pericarditis, postinfarction angina, and reinfarction. Clin Cardiol 1994, 17:471–478.
Roberts BM, Lessof MH: Immunological aspects of cardiovascular disorders. In Progress in Cardiology. Edited by Yu PN, Goodwin JF. Philadelphia: Lea & Febiger; 1973:31.
Scheerder IE, Vandekerckhove J, Robbrecht J, et al.: Post-cardiac injury syndrome and an increased humoral immune response against the major contractile proteins (actin and myosin). Am J Cardiol 1985, 56:631–633.
Lessof MH: Postpericardiotomy syndrome: pathogenesis and management. Hosp Pract 1976, 11:81–86.
Khan AH: The postcardiac injury syndromes. Clin Cardiol 1992, 15:67–72. This paper reviews diagnosis, complications, and treatment post-myocardial infarction and postcardiotomy pericarditis.
Waller BF, Taliercio CP, Howard J, et al.: Morphologic aspects of pericardial heart disease: part II. Clin Cardiol 1992, 15:291–298.
Berman J, Haffajee CI, Alpert JS: Therapy of symptomatic pericarditis after myocardial infarction: retrospective and prospective studies of aspirin, indomethacin, prednisone and spontaneous resolution. Am Heart J 1981, 101:750–753.
Hammerman H, Kloner RA, Schoen FJ, et al.: Indomethacin-induced scar thinning after experimental myocardial infarction. Circulation 1983, 67:1290–1295.
Jugdutt BI, Basualdo CA: Myocardial infarct expansion during indomethacin or ibuprofen therapy for symptomatic post infarction pericarditis. Influence other pharmacologic agents during early remodelling. Can J Cardiol 1989, 5:211–221.
Lichstein E, Liu H-M, Gupta P: Pericarditis complicating acute myocardial infarction: incidence of complications and significance of electrocardiogram on admission. Am Heart J 1973, 87:246–252.
Tsang TSM, Freeman WK, Sinak LJ, Seward JB: Echocardiographically guided pericardiocentesis: evolution and state-of-the-art technique. Mayo Clin Proc 1998, 73:647–652. This paper describes in detail a step-by-step method of performing pericardiocentesis using two-dimensional echocardiographic guidance.
About this article
Cite this article
Indik, J.H., Alpert, J.S. Post-myocardial infarction pericarditis. Curr Treat Options Cardio Med 2, 351–355 (2000). https://doi.org/10.1007/s11936-996-0009-7
- Pericardial Effusion
- Main Side Effect